Search

everythinglearnresearchcommunity

for

Search:↓

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Use of cosmeceuticals during pregnancy and breastfeeding is not recommended due to insufficient safety data.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Prompt diagnosis and treatment of hair tourniquet syndrome involving the uvula are crucial to prevent severe complications.

Most pregnant women experience common skin changes like linea nigra and stretch marks.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Platelet-rich plasma can potentially promote hair growth by stimulating cell growth and increasing certain proteins.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Androgens can both increase and decrease hair growth in different parts of the body.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Estrogen therapy can reduce skin aging but has cancer risks.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Cathepsin L is essential for normal hair growth and development.

Androgens, like testosterone, are crucial for early testicular descent in rats.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.